Fina BioSolutions protein purification services help small biotech companies move from discovery to early clinical trials. We also offer protein expression and immunoassay design services.
Fina BioSolutions bioconjugation services create essential reagents for diagnostic assays, particularly ELISAs. We provide high quality and well characterized amino and carboxyl dextrans (AmDex & CMDex). In addition, we have a propriety chemistry for producing end functionalized dextrans.
We are also noted for expertise in conjugate vaccines, especially protein-polysaccharide conjugate vaccines. Chemistry developed by Andrew Lees, founder of Fina BioSolutions, is used by GlaxoSmithKline and the Serum Institute of India in their S. pneumo conjugate vaccines.
Fina BioSolutions is a "consulting laboratory". We are well equipped to do the above services in our laboratory, as well as to provide consulting services.